Laboratory Reference Grade Compounds
Dataset Reference Standard · In Vitro Titration Matrix

Master Peptide Dosage & Reconstitution Matrix

High-density reference standards for 88 verified analytical peptides and synergistic formulations. Live U-100 syringe unit calibrations, reconstitution concentrations, and pharmacodynamic half-lives sourced directly from published monographs.

Total Monographs
176
Single Peptides
131
Synergistic Blends
20
Multi-Vial Bundles
12
Active in Matrix
161

Master Pharmacodynamic Dosage & Reconstitution Matrix

High-density reference standards for 161 verified analytical peptides & synergistic formulations. Sourced directly from published monographs.

IN VITRO LABORATORY RESEARCH ONLY: This matrix compiles analytical stoichiometry, diluent reconstitution volumes, and titration benchmarks for laboratory reference and scientific inquiry. Not approved for human or veterinary administration.
Research Category:
Delivery Route:
Clinical Evidence Tier:
Phase Projection:Projecting standard target maintenance dose & concentration
Compound & Route ↑Standard Dose Cadence & t½Reconstitution & Conc. U-100 Syringe DrawCycle & WashoutActions
5-Amino-1MQ
Metabolic Signaling & Incretinsoralsubq
50 mg – 100 mg daily
(50000 mcg)
1x Daily (Morning Oral/Oral Research Suspension)t½: ~4–6 Hours (Intracellular NNMT enzymatic inhibition persists >24h)
10 mL Diluent→ 50 mg/mL
100.0 units (1.00 mL)
8 to 12 Weeks continuous assayWashout: 4 Weeks between cohorts
Ace-031 (ActRIIB-Fc)
Growth Hormone Axissubq
500 mcg – 1000 mcg Every 14 Days SubQ
(1000 mcg)
1x Every 14 Days (Bi-Weekly SubQ)t½: ~10 to 15 Days
1 mL Diluent→ 1 mg/mL
100.0 units (1.00 mL)
8 to 16 WeeksWashout: 4 Weeks between research cohorts
ACTH 1-39
Antimicrobial & Immunesubqim
50 mcg – 250 mcg per experimental challenge protocol
(250 mcg)
1x Daily or Intermittent Pulset½: ~15 to 20 Minutes (Plasma half-life)
2 mL Diluent→ 2.5 mg/mL
10.0 IU = 250 mcg at 2.5 mg/mL
Acute to 4 WeeksWashout: 2 Weeks
ADAMAX 1032
Cognitive & Neuroprotectivenasalsubq
250 mcg – 500 mcg daily
(250 mcg)
1x Daily (Morning SubQ or Intranasal)t½: ~4 to 6 Hours (Extended central action via adamantane stabilization)
2 mL Diluent→ 5 mg/mL
5.0 units (0.05 mL)
4 to 8 WeeksWashout: 2 to 4 Weeks between cycles
Adipotide (FTPP)
Metabolic Signaling & Incretinssubq
250 mcg – 500 mcg Daily SubQ (28-Day Cycle)
(250 mcg)
1x Daily (Q24H SubQ for 28-Day Analytical Block)t½: ~2 to 4 Hours
2 mL Diluent→ 5 mg/mL
5.0 units (0.05 mL)
28 Days Maximum per Analytical CycleWashout: 8 Weeks Minimum before re-evaluation
AHK-Cu (Copper Tripeptide-3)
Skin, Hair & Cellular Matrixtopicalsubq
5 mg – 10 mg Topical Scalp Application
(5000 mcg)
1x Daily (Topical Scalp / Dermal Monograph)t½: Localized dermal retention (~24 Hours)
5 mL Diluent→ 10 mg/mL
50.0 units (0.50 mL)
12 to 24 WeeksWashout: 4 Weeks between research cohorts
AICAR
Mitochondrial & Cellular Longevitysubq
10 mg – 25 mg daily
(25000 mcg)
1x Daily (Morning SubQ)t½: ~2 to 4 Hours (Cellular ZMP retention provides extended allosteric AMPK activation)
2 mL Diluent→ 50 mg/mL
50.0 units (0.50 mL)
4 to 6 WeeksWashout: 4 Weeks between cycles
Alprostadil
Photoprotection & Sexual Healthsubqic
5 mcg – 20 mcg experimental microvascular challenge
(10 mcg)
Acute Experimental Challenget½: ~5 to 10 Minutes (Rapid pulmonary clearance)
1 mL Diluent→ 0.02 mg/mL
50.0 IU = 10 mcg at 0.02 mg/mL
Acute Laboratory AssaysWashout: 24 Hours
AOD-9604
Metabolic Signaling & Incretinssubq
300 mcg – 500 mcg daily
(300 mcg)
1x Daily (Fasted Morning SubQ)t½: ~30 Minutes (Rapid plasma clearance; triggers sustained lipolytic signaling without IGF-1 elevation)
2 mL Diluent→ 2.5 mg/mL
12.0 units (0.12 mL)
8 to 12 WeeksWashout: 4 Weeks
600 mcg Combined (300mcg AOD / 150mcg CJC / 150mcg Ipam)
(600 mcg)
1x Daily (Fasted AM or Pre-Bed SubQ)t½: ~30 Minutes to 2 Hours
2.4 mL Diluent→ 5 mg/mL
12.0 units (0.12 mL)
8 to 12 WeeksWashout: 4 Weeks between research cohorts
Showing 1–10 of 161 compounds
Show:
Page 1 of 17